TY - JOUR
T1 - Enhanced T cell apoptosis in common variable immunodeficiency
T2 - Negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS
AU - Di Renzo, M.
AU - Serrano, D.
AU - Zhou, Z.
AU - George, I.
AU - Becker, K.
AU - Cunningham-Rundles, C.
PY - 2001
Y1 - 2001
N2 - CVI is a primary immunodeficiency characterized by a failure of B cell differentiation associated with an array of T cell defects, such as enhanced T cell apoptosis. In this study we investigated the mechanisms underlying CVI enhanced T cell death. We analysed both the expression of Fas using flow cytometry techniques and the expression of FasL mRNA using RT-PCR in CVI T cells. We could not find any significant differences between CVI and normal subjects with regard to Fas expression, although there was a subgroup of CVI patients with very high Fas expression which was accompanied by an up-regulation of FasL mRNA. However, attempts to induce Fas-mediated apoptosis in these high Fas expressing cells, as evaluated by propidium iodide staining and APO2.7 staining, were unsuccessful. We also investigated intracellular levels of Bcl-2, bcl-xl and bax in CD4
+ and CD8
+ CVI T cells, as well as the bax/Bcl-2 ratio, using flow cytometry techniques but could not detect any differences between CVI and normal subjects. Finally we analysed TNF-RI and TNF-RII mRNA expression in CD4
+ and CD8
+ CVI T cells using semiquantitative RT-PCR and found a significant increase in expression of both TNF-Rs in CD4
+ T cells from CVI patients. Our data suggest that the increased expression of both TNF-Rs on T cells may be one of the mechanisms responsible for the accelerated T cell apoptosis in CVI.
AB - CVI is a primary immunodeficiency characterized by a failure of B cell differentiation associated with an array of T cell defects, such as enhanced T cell apoptosis. In this study we investigated the mechanisms underlying CVI enhanced T cell death. We analysed both the expression of Fas using flow cytometry techniques and the expression of FasL mRNA using RT-PCR in CVI T cells. We could not find any significant differences between CVI and normal subjects with regard to Fas expression, although there was a subgroup of CVI patients with very high Fas expression which was accompanied by an up-regulation of FasL mRNA. However, attempts to induce Fas-mediated apoptosis in these high Fas expressing cells, as evaluated by propidium iodide staining and APO2.7 staining, were unsuccessful. We also investigated intracellular levels of Bcl-2, bcl-xl and bax in CD4
+ and CD8
+ CVI T cells, as well as the bax/Bcl-2 ratio, using flow cytometry techniques but could not detect any differences between CVI and normal subjects. Finally we analysed TNF-RI and TNF-RII mRNA expression in CD4
+ and CD8
+ CVI T cells using semiquantitative RT-PCR and found a significant increase in expression of both TNF-Rs in CD4
+ T cells from CVI patients. Our data suggest that the increased expression of both TNF-Rs on T cells may be one of the mechanisms responsible for the accelerated T cell apoptosis in CVI.
KW - Apoptosis
KW - Bcl-2 protein family
KW - CVI
KW - Fas/FasL
KW - T lymphocytes
KW - TNF-Rs
UR - http://www.scopus.com/inward/record.url?scp=0034905537&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034905537&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2249.2001.01560.x
DO - 10.1046/j.1365-2249.2001.01560.x
M3 - Article
C2 - 11472434
AN - SCOPUS:0034905537
VL - 125
SP - 117
EP - 122
JO - Clinical and Experimental Immunology
JF - Clinical and Experimental Immunology
SN - 0009-9104
IS - 1
ER -